Back to Screener

Healthcare

Intellia Therapeutics, Inc.(NTLA)

Live Price

Offline

$16.03

+3.42% today

1Y Change

+63.91%

Window

Jun 27, 2025 โ†’ Jun 18, 2026

Market Cap
$1.57B
Revenue Growth
+16.9%
EPS Growth
+27.4%
Dividend Yield
0.0%

Coverage: 245 bars ยท Jun 27, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Intellia Therapeutics, Inc. (NTLA) is a Healthcare stock with a market cap of $1.57B and listed on NASDAQ. The stock last traded around $16.03 and up 63.9% across the available one-year price window (Jun 27, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +16.9%, EPS growth of +27.4%, a dividend yield of 0.0%. What stands out right now is revenue +16.9%, EPS +27.4%, free cash flow 0.0% with operating margin -651.7% and ROIC -57.7%. Valuation already assumes a fairly strong business story at price/sales 23.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines NTLA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

NTLA vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

NTLA

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

NTLA Max Drawdown

-71.27%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for NTLA and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 14, 26
โ€”
Est -0.94
โ€”
โ€”
Est 13568.4B
โ€”
May 14
โ€”
Feb 26, 26
โœ“
-0.83
Est -0.99
+16.2%
23017.0B
Est 11981.8B
+92.1%
Feb 26
โ€”
Nov 6, 25
โœ“
-0.92
Est -1.02
+9.8%
13782.0B
Est 12173.0B
+13.2%
Nov 6
โ€”
Aug 7, 25
โœ“
-0.99
Est -1.03
+3.9%
14245.0B
Est 14063.1B
+1.3%
Aug 7
โ€”
May 8, 25
โœ“
-1.10
Est -1.26
+12.7%
16627.0B
Est 11932.5B
+39.3%
May 8
โ€”
Feb 27, 25
โœ“
-1.24
Est -1.32
+6.1%
12874.0B
Est 10860.5B
+18.5%
Feb 27
โ€”
Nov 7, 24
โœ“
-1.34
Est -1.37
+2.2%
9111.0B
Est 8904.5B
+2.3%
Nov 7
โ€”
Aug 8, 24
โœ—
-1.31
Est -1.21
-8.3%
6957.0B
Est 19160.0B
-63.7%
Aug 8
โ€”
May 9, 24
โœ“
-1.06
Est -1.35
+21.5%
28935.0B
Est 11500.0B
+151.6%
May 9
โ€”
Feb 22, 24
โœ“
-1.46
Est -1.47
+0.7%
1917.0B
Est 12830.0B
-85.1%
Feb 22
โ€”
Nov 9, 23
โœ“
-1.38
Est -1.52
+9.2%
11992.0B
Est 12450.0B
-3.7%
Nov 9
โ€”
Aug 3, 23
โœ—
-1.40
Est -1.32
-6.1%
13594.0B
Est 12080.0B
+12.5%
Aug 3
โ€”
May 4, 23
โœ“
-1.17
Est -1.41
+17.0%
12606.0B
Est 11830.0B
+6.6%
May 4
โ€”
Feb 23, 23
โ€”
-1.40
Est -1.40
0.0%
13573.0B
Est 11333.4B
+19.8%
Feb 23
โ€”
Nov 3, 22
โœ—
-1.49
Est -1.31
-13.7%
13266.0B
Est 11886.0B
+11.6%
Nov 3
โ€”
Aug 4, 22
โœ—
-1.33
Est -1.31
-1.5%
14030.0B
Est 9416.0B
+49.0%
Aug 4
โ€”
May 5, 22
โœ—
-1.96
Est -1.11
-76.6%
11252.0B
Est 8540.4B
+31.8%
May 5
โ€”
Feb 24, 22
โœ—
-1.09
Est -0.91
-19.8%
12854.0B
Est 8262.4B
+55.6%
Feb 24
โ€”
Nov 4, 21
โœ—
-0.97
Est -0.85
-14.1%
7204.0B
Est 9490.0B
-24.1%
Nov 4
โ€”
Aug 5, 21
โœ—
-1.01
Est -0.61
-65.6%
6550.0B
Est 5580.9B
+17.4%
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar